An assessment of change in asthma control among adolescents and adults with persistent asthma in mometasone furoate/formoterol fumarate clinical trials.

Wyrwich, Kathleen W; Ireland, Andrea M; Navaratnam, Prakash; Nolte, Hendrik; Gates, Davis F

Wyrwich, Kathleen W; Ireland, Andrea M; Navaratnam, Prakash; Nolte, Hendrik; Gates, Davis F.

Affiliation

Wyrwich KW; United BioSource Corporation, Bethesda, MD 20814, USA. kathy.wyrwich@unitedbiosource.com

J Asthma ; 48(1): 48-56, 2011 Feb.

Article in En | MEDLINE | ID: mdl-21039190

Subject(s)

Adrenergic beta-2 Receptor Agonists/administration & dosage; Anti-Asthmatic Agents/administration & dosage; Asthma/drug therapy; Asthma/psychology; Bronchodilator Agents/administration & dosage; Ethanolamines/administration & dosage; Pregnadienediols/administration & dosage; Quality of Life; Administration, Inhalation; Adolescent; Adult; Anti-Asthmatic Agents/therapeutic use; Asthma/physiopathology; Child; Drug Therapy, Combination; Female; Formoterol Fumarate; Humans; Male; Mometasone Furoate; Peak Expiratory Flow Rate; Psychometrics; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Vital Capacity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnadienediols / Quality of Life / Asthma / Bronchodilator Agents / Anti-Asthmatic Agents / Ethanolamines / Adrenergic beta-2 Receptor Agonists Type of study: Clinical_trials / Prognostic_studies / Qualitative_research Aspects: Patient_preference Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: J Asthma Year: 2011 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google